Top

Annals of Surgical Oncology

Published in:

01-02-2011 | Breast Oncology

Twelve-Month Follow-Up Results of a Trial Utilizing Axxent Electronic Brachytherapy to Deliver Intraoperative Radiation Therapy for Early-Stage Breast Cancer

Authors: Olga Ivanov, MD, Adam Dickler, MD, Bennett Y. F. Lum, MD, James V. Pellicane, MD, Darius S. Francescatti, MD

Published in: Annals of Surgical Oncology | Issue 2/2011

Abstract

Background

Accelerated partial breast irradiation (APBI) is emerging as a valid alternative to whole-breast radiation therapy (WBRT) in breast-conserving therapy (BCT) for early-stage breast cancer. Axxent electronic brachytherapy (EBX) is a form of portable, balloon-based APBI that utilizes an electronic source of kilovoltage irradiation delivery with minimal shielding requirements. As such, EBX becomes a logical and convenient modality for delivery of intraoperative radiation therapy (IORT). We report 1-year results and clinical outcomes of a trial that utilizes EBX to deliver IORT for patients with early-stage breast cancer.

Methods

Eleven patients were enrolled on an institutional review board (IRB)-approved protocol. Inclusion criteria were patient age >45 years, unifocal tumors with infiltrating ductal or ductal carcinoma in situ (DCIS) histology, tumors ≤3 cm, and uninvolved lymph nodes. Preloaded radiation plans were used to deliver radiation prescription dose of 20 Gy to the balloon surface.

Results

The mean time for radiation delivery was 22 min; the total mean procedure time was 1 h 39 min. All margins of excision were negative on final pathology. At mean follow-up of 12 months, overall cosmesis was excellent in 10 of 11 patients. No infection, fat necrosis, desquamation, rib fracture or cancer recurrence has been observed. There was no evidence of fibrosis at last follow-up.

Conclusion

IORT utilizing EBX is emerging as a feasible, well-tolerated alternative to postsurgical APBI. Further research and longer follow-up data on EBX and other IORT methods are needed to establish the clinical efficacy and safety of this treatment.

Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef

Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002:341:1233–41.CrossRef

Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1097–101.PubMedCrossRef

Dolan JT, Granchi TS, Miller CC, Brunicardi, FC. Low use of breast conservation surgery in medically indigent populations. Am J Surg. 1999;178:470–4.PubMedCrossRef

Hahn CA, Marks LB, Chen DY, Lind PA, Lind HM, Prosnitz LR. Breast conservation rates –barriers between tertiary care and community practice. Int J Radiat Oncol Biol Phys. 2003;55(5):1196–9.PubMedCrossRef

Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366(9503):2087–106.PubMed

Chen PY, Wallace M, Mitchell C, et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76(4):991–7.PubMedCrossRef

Nelson J, Beitsch P, Vicini F et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite Brachytherapy trial. Am J Surg. 2009;198(1):83–92.PubMedCrossRef

Dirbas F. Accelerated partial breast irradiation: where do we stand? J Natl Compr Canc Netw. 2009;7(2):215–25.PubMed

10.

Dickler A, Kirk M, Seif N, et al. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy. 2007;6:164–8.PubMedCrossRef

11.

Mehta VK, Algan O, Griem KL, et al. Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation. Am J Clin Oncol. 2010;33(4):327–35.PubMedCrossRef

12.

Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 2001;37(17):2178–84.PubMedCrossRef

13.

Holmes D, Baum M, Joseph D. The targit trial: targeted intraoperative radiation therapy versus conventional postoperative whole breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg. 2007;194:507–10.PubMedCrossRef

14.

Baum M, Vaidya J. Targeted intra-operative radiotherapy-TARGIT for early breast cancer. Ann N Y Acad Sci. 2008;1138:132–5.PubMedCrossRef

15.

Chen Z, King W, Pearcey R, Kerba M, Mickillop W. The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature. Radiother Oncol. 2008;87:3–16.PubMedCrossRef

16.

Bartelink H. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–87.PubMedCrossRef

17.

Athas W, Adams-Cameron M, Hunt W, Amir-Fazli A, Key C. Travel distance to radiation therapy and receipt of radio-therapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269–71.PubMedCrossRef

18.

Kurniawan E, Wong M, Windle I. Predictors of surgical margin status in breast-conserving surgery within a breast-screening program. Ann Surg Oncol. 2008;15:2542–9.PubMedCrossRef

19.

Highes L, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27:5319–24.CrossRef

Title: Twelve-Month Follow-Up Results of a Trial Utilizing Axxent Electronic Brachytherapy to Deliver Intraoperative Radiation Therapy for Early-Stage Breast Cancer
Authors: Olga Ivanov, MD
Adam Dickler, MD
Bennett Y. F. Lum, MD
James V. Pellicane, MD
Darius S. Francescatti, MD
Publication date: 01-02-2011
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 2/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-010-1283-x

At a glance: The STEP trials

Springer Medicine

Twelve-Month Follow-Up Results of a Trial Utilizing Axxent Electronic Brachytherapy to Deliver Intraoperative Radiation Therapy for Early-Stage Breast Cancer

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2011

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study

Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable Intrahepatic Cholangiocellular Carcinoma: Optimal Tolerance and Prolonged Overall Survival

Sentinel Node Dissection Delays Recurrence and Prolongs Melanoma-Related Survival: An Analysis of 673 Patients from a Single Center with Long-Term Follow-Up

Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial

Reply to “25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients With Primary Hyperparathyroidism,” by Agarwal et al.

Impact of Circumferential Resection Margin Distance on Locoregional Recurrence and Survival after Chemoradiotherapy in Esophageal Squamous Cell Carcinoma